Chinese Herbal Medicines

SCIE

国际简称：CHIN HERB MED 参考译名：中草药

主要研究方向：CHEMISTRY, MEDICINAL 非预警期刊审稿周期：10 Weeks

《中草药》(Chinese Herbal Medicines)是一本由Elsevier出版的以CHEMISTRY, MEDICINAL为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

1区中科院分区
Q1 JCR分区
69 年发文量
11.2 IF影响因子
未开放 是否OA
4 issues/year 出版周期
English 出版语言

Chinese Herbal Medicine (quarterly) was founded in 2009 and is the first professional journal in the field of Chinese herbal medicine to be published in English. The purpose and business scope of the publication are to inherit and carry forward the heritage of traditional Chinese medicine, report and reflect on the latest progress in traditional Chinese medicine research, promote the traditional characteristics of Chinese medicine in China, strengthen the exchange of experience in traditional medicine research with countries around the world, build a bridge of understanding and communication between traditional Chinese medicine and Western medicine, tradition and modernity, and East and West, and promote the modernization and internationalization of traditional Chinese medicine.

The purpose of this publication is to provide a forum for the study of Chinese herbal medicine, traditional medicines, and natural products. This journal includes research on the active ingredients and complex formulations of herbs in medicinal resources, phytochemistry, pharmacology, toxicology, pharmacokinetics, and therapeutic functions through experiments and clinical trials. Introducing the latest developments in pharmaceutical science to readers is of interest to this journal.

[ 查看全部 ]

投稿咨询加急咨询

Chinese Herbal Medicines期刊信息

ISSN：1674-6384
出版语言：English
是否OA：未开放
E-ISSN：1674-6384
出版地区：Netherlands
是否预警：否
出版商：Elsevier
出版周期：4 issues/year
开源占比：0.9777
Gold OA文章占比：100.00%
OA被引用占比：0.1564...
出版国人文章占比：0.72
出版撤稿占比：
研究类文章占比：68.12%

Chinese Herbal Medicines CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

13.5

1.456

2.008

学科类别	分区	排名	百分位
大类：Medicine 小类：Complementary and Alternative Medicine	Q1	1 / 115	99%
大类：Medicine 小类：Pharmacology (medical)	Q1	12 / 278	95%
大类：Medicine 小类：Pharmacology	Q1	20 / 328	94%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Chinese Herbal Medicines中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	CHEMISTRY, MEDICINAL 药物化学 INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学	1区 1区

Chinese Herbal Medicines JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CHEMISTRY, MEDICINAL	ESCI	Q1	4 / 72	95.1
学科：CHEMISTRY, MEDICINAL	ESCI	Q1	4 / 72	95.14

Chinese Herbal Medicines历年数据统计

影响因子

中科院分区

Chinese Herbal Medicines中国学者发文选摘

1、Diverse alkaloids with anti-inflammatory activity discovered from Thalictrum baicalens
Author: Yang, Jinyuan; Chen, Zhaojing; Xue, Jingjing; Ren, Yikun; Li, Zhanlin; Li, Dahong; Sun, Yating; Hua, Huiming

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 487-490. DOI: 10.1016/j.chmed.2026.02.013
2、Efficacy and safety of Toujie Quwen Granules in patients infected with SARS-CoV-2: A prospective cohort study of 156 case
Author: Xu, Qihua; Zhang, Xinyue; Huang, Sanqi; Li, Linghua; Li, Feng; Liu, Wei; Ling, Kunzhou; Guan, Jialong; Tan, Xinghua; Lin, Luping

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 303-311. DOI: 10.1016/j.chmed.2026.02.016
3、Anti-influenza formula medicines based on warm disease theory of traditional Chinese medicin
Author: Xiao, Mengjie; Huang, Tao; Qin, Shengle; Zhang, Tianbo; Li, Runfeng; Zhao, Xin; Lin, Luping; Yang, Zifeng

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 231-240. DOI: 10.1016/j.chmed.2026.02.008
4、Biosynthetic pathway analysis of ginsenoiside Rh1 to notoginsenoside R
Author: Wang, Rubing; Zhang, Yanan; Zhang, Huanyu; Yang, Wenqi; Su, Yaowu; Jing, Hongyan; Wang, Juan; Gao, Wenyuan

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 484-486. DOI: 10.1016/j.chmed.2026.02.001
5、Future prospects of antiviral research in traditional Chinese medicin
Author: Wang, Kexin; Yang, Zifeng

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 226-230. DOI: 10.1016/j.chmed.2026.02.014
6、Shuxuening injection for acute ischemic stroke: Efficacy and safety-a randomized, double-blind, placebo controlled, multi-center clinical tria
Author: Ma, Ruihong; Li, Xiaogang; An, Xiaolei; Li, Juntao; Zhu, Jianguo; Temuqile; Zhan, Liping; Zhou, Peiyang; Ren, Baolong; Wang, Baoai; Sun, Yuanyuan; Xiao, Wei; Xu, Men

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 461-469. DOI: 10.1016/j.chmed.2024.12.004
7、Integrated network pharmacology and metabolomics to analyze the mechanism of Shaofu Zhuyu Decoction in treatment of dysmenorrhea of cold coagulation and blood stasi
Author: Luo, Yilu; Wu, Zengguang; Ji, Ruifeng; Shen, Lingling; He, Xin

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 420-438. DOI: 10.1016/j.chmed.2025.02.002
8、Optimization of imperatorin extraction from Qianliexin Capsules using deep eutectic solven
Author: Liu, Cejia; Bai, Hezheng; Liu, Jianxiang; Zhou, Xunyong; Liang, Ning; Shen, Tao; Zhao, Longshan

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 452-460. DOI: 10.1016/j.chmed.2025.03.005